Jubilant Life Sciences has issued Commercial Papers (CPs) aggregating to Rs 50 crore on November 3, 2017. The tenure of the instrument is 55 days and allotted on November 3, 2017. The coupon/interest will be paid upfront at the rate of 6.60% per annum on maturity i.e. December 28, 2017. With this issue, the aggregate amount of commercial papers outstanding as on date is Rs 100 crore.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1676.00 |
| Dr. Reddys Lab | 1234.90 |
| Cipla | 1239.00 |
| Zydus Lifesciences | 947.70 |
| Lupin | 2332.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: